XML 13 R2.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Balance Sheet (Unaudited) - USD ($)
Dec. 31, 2015
Sep. 30, 2015
CURRENT ASSETS    
Cash $ 193,386 $ 76,355
Prepaid Expenses 16,000 25,000
Note Receivable 12,051 12,051
Interest Receivable 1,681 $ 1,381
Due from Former Subsidiary Employee 15,000
Total Current Assets 238,118 $ 114,787
OTHER ASSETS    
Deposits 4,200 4,200
Available for Sale Securities 121,000 159,720
Total Other Assets 125,200 163,920
TOTAL ASSETS 363,318 278,707
CURRENT LIABILITIES    
Accounts Payable 169,769 167,977
Notes Payable 347,036 400,336
Bank Overdraft 0 0
Accrued Payroll 784,757 738,095
Accrued Payroll Taxes 48,316 44,485
Accrued Interest 337,721 324,750
Accrued Rent 10,000 10,000
Accrued Expenses 5,000 5,000
Convertible Note Payable Net of Unamortized Discount 211,675 231,507
Due to Affiliate 0 0
Due to Subsidiary Shareholder 50,000 0
Current portion, note payable to affiliated party 1,000 1,000
Total Current Liabilities 1,965,274 1,923,150
Total Liabilities 1,965,274 1,923,150
STOCKHOLDERS EQUITY (DEFICIT)    
Preferred Stock ($.0001 par value) 20,000,000 shares authorized; 20,000,000 shares authorized; 2063821 issues and outstanding as of September 30 2015 and December 31, 2015 207 207
Series AA Preferred ($0.0001 par value) 100,000 shares authorized 94,852 issued and outstanding as of September 30, 2015 and December 31, 2015 9 9
Series AAA Preferred ($0.0001 par value) 1,000,000 shares authorized 40,000 shares issued and outstanding as of September 30, 2015 and December 31, 2015 4 4
Series B Preferred Shares ($.0001 par value) 2,000,000 shares authorized; 725,409 issued and outstanding as of December 31, 2015 and September 30,2015 respectively 73 73
Common Stock ($.0001 par value) 5,000,000,000 shares authorized and 4,232,931,345 issued and outstanding as of September 30, 2015, 8,000,000,000 shares authorized and4,889,065,929 shares issued and outstanding as of December 31, 2015 488,905 423,292
Non Voting Converible Preferred Stock ($1 Par value) 200,000 shares authorized; 0 shares issued and outstanding as of September 30, 2015 and December 31, 2015 0 0
Additional Paid in capital 31,059,493 29,004,809
Contributed Capital 509,355 509,355
Retained Earnings (Deficit) 7,552,077 9,704,398
Accumulated Other Comprehensive Income (Loss) (41,407,361) (41,368,641)
Total Stockholders' Equity (Deficit) Biomatrix Scientific Group, Inc. (1,797,238) (1,726,494)
Noncontrolling Interest in subsidiary 195,283 82,050
Total Stockholders' Equity (1,601,955) (1,644,444)
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT) $ 363,318 $ 278,707